Cel
Survivors of acute myocardial infarction (MI) are at a particularly high risk for accelerated atherosclerosis and recurrent atherothromobosis. Nevertheless, mechanistic preclinical studies in atherosclerosis research world-wide are typically conducted in unchallenged (without MI) atherosclerosis-prone mice and thus do not address the specific pathophysiology of post-MI atherosclerotic cardiovascular disease. We conducted a single-cell RNA sequencing coupled to B cell receptor (BCR) sequencing analysis of sorted CD45+ splenocytes from atherosclerosis-prone mice that were fed an atherogenic diet for eight weeks in total and were subjected four weeks after the initiation of the atherogenic diet feeding either to sham microsurgery or to permanent ligation of the left anterior descending coronary artery to induce MI. We found that splenic mature B lymphocytes from atherosclerotic mice that suffered an MI display altered glucocorticoid-induced responses and a more diversified BCR repertoire, which contains twelve unique clonotypes (named B-MIracle clones) that are not present in atherosclerotic mice without MI.
Here, I aim a) to investigate the effect of glucocorticoid-induced signaling in B cells in post-MI atherosclerosis in vivo by employing mouse models that allow the inducible genetic manipulation of different components of the glucocorticoid-induced signaling axis, b) by utilizing the full heavy and light chain nucleotide sequences from our single cell BCR-seq data, to clone and produce the respective antibodies of the B-MIracle clones and examine their effect in accelerated atherosclerosis after MI in vivo, and c) to address the relevance of these findings in atherosclerosis progression in patients with a recent MI, by analyzing sorted peripheral B cell subsets and serum samples. These studies may lead to the identification of precise therapeutic targets for secondary prevention of cardiovascular disease.
Dziedzina nauki
- medical and health sciencesbasic medicinephysiologypathophysiology
- medical and health sciencesmedical biotechnologygenetic engineering
- medical and health sciencesclinical medicinecardiologycardiovascular diseasesarteriosclerosis
- medical and health scienceshealth sciencesnutrition
- natural sciencesbiological sciencesgeneticsnucleotides
Program(-y)
- HORIZON.1.1 - European Research Council (ERC) Main Programme
Temat(-y)
System finansowania
HORIZON-AG - HORIZON Action Grant Budget-BasedInstytucja przyjmująca
1090 Wien
Austria